Antiparkinson Agents (diagnostic use) < Antiparkinson Agents (economics) < Antiparkinson Agents (history)

Facettes :

List of bibliographic references indexed by Antiparkinson Agents (economics)

Number of relevant bibliographic references: 10.

Ident.	Authors (with country if any)	Title
000522 (2014)	Mathias Toft [Norvège] ; Espen Dietrichs	Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease.
001A94 (2010)	Mário Miguel Rosa [Portugal] ; Joaquim J. Ferreira [Portugal] ; Miguel Coelho [Portugal] ; Rita Freire [Portugal] ; Cristina Sampaio [Portugal]	Prescribing patterns of antiparkinsonian agents in Europe
002770 (2008)	Amit S. Kulkarni [États-Unis] ; Rajesh Balkrishnan [États-Unis] ; Roger T. Anderson [États-Unis] ; Heather M. Edin [États-Unis] ; Jeff Kirsch [Royaume-Uni] ; Mark A. Stacy [États-Unis]	Medication adherence and associated outcomes in medicare health maintenance organization‐enrolled older adults with Parkinson's disease
003468 (2006)	Gang Wang [République populaire de Chine] ; Qi Cheng [République populaire de Chine] ; Rui Zheng [République populaire de Chine] ; Yu-Yan Tan [République populaire de Chine] ; Xiao-Kang Sun [République populaire de Chine] ; Hai-Yan Zhou [République populaire de Chine] ; Xiao-Lai Ye [République populaire de Chine] ; Ying Wang [République populaire de Chine] ; Zeng Wang [République populaire de Chine] ; Bo-Min Sun [République populaire de Chine] ; Sheng-Di Chen [République populaire de Chine]	Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China
003486 (2006)	Mona Ragothaman [Inde] ; Shyla T. Govindappa [Inde] ; Rohini Rattihalli [Inde] ; Dodaballapur K. Subbakrishna [Inde] ; Uday B. Muthane [Inde]	Direct costs of managing Parkinson's disease in india: Concerns in a developing country
003853 (2005)	Katherine A. Grosset [Royaume-Uni] ; John L. Reid [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]	Medicine‐taking behavior: Implications of suboptimal compliance in Parkinson's disease
003B68 (2004)	Connie Marras [Canada]	Re: Cabergoline versus levodopa monotherapy: A decision analysis
003D89 (2004)	Keith Wheatley [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Richard Gray [Royaume-Uni]	Cabergoline versus levodopa monotherapy
004165 (2003)	Antje M. Smala [Allemagne] ; E. Annika Spottke [Allemagne] ; Olaf Machat [Allemagne] ; Uwe Siebert [États-Unis] ; Dieter Meyer [Allemagne] ; Rudolf Köhne-Volland [Allemagne] ; Martin Reuther [Allemagne] ; Janeen Duchane [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; Karin B. Berger [Allemagne] ; Richard C. Dodel [Allemagne]	Cabergoline versus levodopa monotherapy: A decision analysis
005036 (1998)	Dodel [Allemagne] ; Karla M. Eggert [Allemagne] ; Marika S. Singer [Allemagne] ; Tobias E. Eichhorn [Allemagne] ; Oliver Pogarell [Allemagne] ; Wolfgang H. Oertel [Allemagne]	Costs of drug treatment in Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiparkinson Agents (economics)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiparkinson Agents (economics)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (economics)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024